The risks of ischemic and hemorrhagicstroke and poor neurological outcomes after stroke are increased in people with type 2 diabetes. Explore how to manage the hyperacute stroke stage and CV disease prevention.
STEP-HFpEF trial findings indicate that weekly semaglutide improves heart failure symptoms, physical limitations, and body weight in people with obesity-related heart failure and type 2 diabetes.
The Improving Diabetes Steering Committee outlines the place, value, and advantages of SGLT2 inhibitors in the treatment of type 2 diabetes. With user-friendly tools to support their use.
This UK consensus guideline provides a practical approach to the assessment and management of type 2 diabetes and associated complications in children and young people.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.
Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.
Metformin-associated lactic acidosis can cause acute blindness, but vision may be recovered by timely treatment of acidosis. Physicians should be aware that even if patients have severe metabolic acidosis they can still have stable vital signs.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Type 2 DiabetesDiabetes and Cardiovascular Disease (D Bruemmer, Section Editor)
Type 2 diabetes (T2D) is a major health care problem in the US, affecting approximately 37 million Americans or ~ 10% of the adult population, and for every person with T2D, there ~ 2 individuals with prediabetes [ 1 ]. Cardiovascular disease (CVD) …
Type 2 diabetes mellitus (T2DM) is a global health concern, and its prevalence has been steadily increasing over the years [ 1 ]. The International Diabetes Federation (IDF) estimated that approximately 537 million adults (ages 20–79) were living …
The rising prevalence of type 2 diabetes (T2D) is posing major challenges for the healthcare systems of many countries, particularly in the Asia–Pacific Region, in which T2D can present at younger ages and lower body mass index when compared with …
Semaglutide, administered s.c., has shown superior efficacy compared with other glucose-lowering agents, including its oral formulation, in reducing HbA 1c and in facilitating weight loss in individuals with type 2 diabetes [ 1 , 2 ]. Initially …
An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
An independent educational program featuring simulated patient consultations. Make knowledge-based decisions on diagnosis and management of CKD with and without co-morbidities, and learn from experts Kevin Fernando and David Wheeler.
Guidelines for 24 h movement [ 1 , 2 ] are based on evidence that behaviours composing a day (sitting, standing, physical activity and sleep) can have interrelated contributions to health. Changing time spent in one of these behaviours will …
Multiple daily injection insulin regimen (MDI), also referred to as intensive insulin therapy (IIT), represents the most complex type of insulin regimen used in the management of people with type 2 diabetes (PwT2D). Correspondingly, MDI regimen …
Quality of life (QOL) of patients is an important factor in continuing diabetes management. Current Japanese guidelines recommend pharmacotherapy to maintain patients’ QOL in addition to the consideration of appropriate targets for glucose …
Cardiovascular and kidney complications contribute to excess morbidity and mortality in individuals with type 2 diabetes mellitus [ 1 ]. Besides lifestyle interventions, current guidelines recommend a combination of drugs to prevent or delay the …